Literature DB >> 31830834

Early Speech Rate Development: A Longitudinal Study.

Anna Tendera1, Matthew Rispoli2, Ambikaipakan Senthilselvan3, Torrey M Loucks1.   

Abstract

Purpose Our knowledge of speech rate development remains inadequate because of limited longitudinal data and lack of data from children under age 3;0 (years;months). The purpose of this longitudinal study was to test the pattern of speech rate development between ages 2;0 and 3;0. Method Speech rate was assessed at 4 time points between ages 2;0 and 3;0. The analysis employed multilevel models to characterize the development of speech rate (syllables per second), phonemes per second (PPS), length of active declarative sentences, and mean length of utterance. Results The results indicate a significant linear increase in speech rate, PPS, length of active declarative sentences, and mean length of utterance occurring over the 1-year period. Male and female children differed in speech rate, PPS, and utterance length, suggesting sex is a potential factor in early speech rate development. Conclusions Our findings indicate that the speech motor system develops rapidly during the period when grammar emerges. Speech rate has the potential to be an important metric for understanding typical speech development and speech disorders.

Entities:  

Year:  2019        PMID: 31830834     DOI: 10.1044/2019_JSLHR-19-00145

Source DB:  PubMed          Journal:  J Speech Lang Hear Res        ISSN: 1092-4388            Impact factor:   2.297


  2 in total

1.  Explicating Child-Driven Patterns of Parent-Child Responsivity in Fragile Families: A Longitudinal Approach.

Authors:  Jessica Blume; SuJung Park; Miranda Cox; Ann M Mastergeorge
Journal:  Front Pediatr       Date:  2022-03-15       Impact factor: 3.418

2.  Speech Development Between 30 and 119 Months in Typical Children II: Articulation Rate Growth Curves.

Authors:  Tristan J Mahr; Jennifer U Soriano; Paul J Rathouz; Katherine C Hustad
Journal:  J Speech Lang Hear Res       Date:  2021-09-29       Impact factor: 2.674

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.